Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs

K. M. Merchant, D. J. Dobie, Daniel Dorsa

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

In this chapter, we have presented evidence for several potential levels of interaction of NT/N gene products with dopaminergic systems of the brain. We have focused on one manifestation of this interaction related to the effects of antipsychotic drugs on expression of the NT/N gene in two anatomically discrete populations of neurons. It appears that certain antipsychotic drugs can dramatically increase expression of this gene in the dorsolateral striatum by blocking dopamine D2 receptors, perhaps by increasing expression of the gene encoding the transcriptional regulator fos. In addition, a second group of NT cells in the shell region of the nucleus accumbens also respond to these drugs by increasing NT/N gene expression. Several other peptides have been suggested to respond to treatment with antipsychotic drugs. However, there are some important differences with respect to their effects on the NT cells we have studied. The most important of these is the differential responsiveness of the DLSt and nucleus accumbens NT neurons to typical and atypical antipsychotics. We showed that all antipsychotic drugs tested increased NT/N mRNA gene expression in the accumbens, a region thought to be involved in dopaminergic disturbances underlying psychosis. However, only the typical neuroleptics that have a high propensity to induce acute extrapyramidal motor side effects influenced NT/N gene expression in the dorsolateral striatum, a structure importantly involved in regulation of motor functions. We hypothesize, therefore, that NT/N-expressing neuronal systems in the nucleus accumbens may mediate some or all of the antipsychotic effects, whereas those in the dorsolateral striatum may be involved in motor effects of neuroleptic drugs. Thus, examination of the effects of these drugs on these neuronal populations will not only clarify their mechanism of action, but in addition may provide a useful 'screening' assay for new drugs with enhanced antipsychotic activity, but reduced propensity to induce the debilitating extrapyramidal side effects that are a major cause of patient noncompliance. Future studies will focus on the effects of antipsychotic drugs on NT neurons in clinically relevant models of chronic administration, and on the molecular events involved in their effects on expression of the NT/N gene in the brain.

Original languageEnglish (US)
Pages (from-to)54-69
Number of pages16
JournalAnnals of the New York Academy of Sciences
Volume668
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Antipsychotic Agents
Rats
Brain
Genes
Gene Expression
Nucleus Accumbens
Gene expression
Neurons
proneurotensin
Rat
Drugs
Gene
Pharmaceutical Preparations
Gene encoding
Dopamine D2 Receptors
Patient Compliance
Psychotic Disorders
Population
Assays
Screening

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs. / Merchant, K. M.; Dobie, D. J.; Dorsa, Daniel.

In: Annals of the New York Academy of Sciences, Vol. 668, 1992, p. 54-69.

Research output: Contribution to journalArticle

@article{82eb5a174982465fabf6e0e6959721dd,
title = "Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs",
abstract = "In this chapter, we have presented evidence for several potential levels of interaction of NT/N gene products with dopaminergic systems of the brain. We have focused on one manifestation of this interaction related to the effects of antipsychotic drugs on expression of the NT/N gene in two anatomically discrete populations of neurons. It appears that certain antipsychotic drugs can dramatically increase expression of this gene in the dorsolateral striatum by blocking dopamine D2 receptors, perhaps by increasing expression of the gene encoding the transcriptional regulator fos. In addition, a second group of NT cells in the shell region of the nucleus accumbens also respond to these drugs by increasing NT/N gene expression. Several other peptides have been suggested to respond to treatment with antipsychotic drugs. However, there are some important differences with respect to their effects on the NT cells we have studied. The most important of these is the differential responsiveness of the DLSt and nucleus accumbens NT neurons to typical and atypical antipsychotics. We showed that all antipsychotic drugs tested increased NT/N mRNA gene expression in the accumbens, a region thought to be involved in dopaminergic disturbances underlying psychosis. However, only the typical neuroleptics that have a high propensity to induce acute extrapyramidal motor side effects influenced NT/N gene expression in the dorsolateral striatum, a structure importantly involved in regulation of motor functions. We hypothesize, therefore, that NT/N-expressing neuronal systems in the nucleus accumbens may mediate some or all of the antipsychotic effects, whereas those in the dorsolateral striatum may be involved in motor effects of neuroleptic drugs. Thus, examination of the effects of these drugs on these neuronal populations will not only clarify their mechanism of action, but in addition may provide a useful 'screening' assay for new drugs with enhanced antipsychotic activity, but reduced propensity to induce the debilitating extrapyramidal side effects that are a major cause of patient noncompliance. Future studies will focus on the effects of antipsychotic drugs on NT neurons in clinically relevant models of chronic administration, and on the molecular events involved in their effects on expression of the NT/N gene in the brain.",
author = "Merchant, {K. M.} and Dobie, {D. J.} and Daniel Dorsa",
year = "1992",
doi = "10.1111/j.1749-6632.1992.tb27339.x",
language = "English (US)",
volume = "668",
pages = "54--69",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs

AU - Merchant, K. M.

AU - Dobie, D. J.

AU - Dorsa, Daniel

PY - 1992

Y1 - 1992

N2 - In this chapter, we have presented evidence for several potential levels of interaction of NT/N gene products with dopaminergic systems of the brain. We have focused on one manifestation of this interaction related to the effects of antipsychotic drugs on expression of the NT/N gene in two anatomically discrete populations of neurons. It appears that certain antipsychotic drugs can dramatically increase expression of this gene in the dorsolateral striatum by blocking dopamine D2 receptors, perhaps by increasing expression of the gene encoding the transcriptional regulator fos. In addition, a second group of NT cells in the shell region of the nucleus accumbens also respond to these drugs by increasing NT/N gene expression. Several other peptides have been suggested to respond to treatment with antipsychotic drugs. However, there are some important differences with respect to their effects on the NT cells we have studied. The most important of these is the differential responsiveness of the DLSt and nucleus accumbens NT neurons to typical and atypical antipsychotics. We showed that all antipsychotic drugs tested increased NT/N mRNA gene expression in the accumbens, a region thought to be involved in dopaminergic disturbances underlying psychosis. However, only the typical neuroleptics that have a high propensity to induce acute extrapyramidal motor side effects influenced NT/N gene expression in the dorsolateral striatum, a structure importantly involved in regulation of motor functions. We hypothesize, therefore, that NT/N-expressing neuronal systems in the nucleus accumbens may mediate some or all of the antipsychotic effects, whereas those in the dorsolateral striatum may be involved in motor effects of neuroleptic drugs. Thus, examination of the effects of these drugs on these neuronal populations will not only clarify their mechanism of action, but in addition may provide a useful 'screening' assay for new drugs with enhanced antipsychotic activity, but reduced propensity to induce the debilitating extrapyramidal side effects that are a major cause of patient noncompliance. Future studies will focus on the effects of antipsychotic drugs on NT neurons in clinically relevant models of chronic administration, and on the molecular events involved in their effects on expression of the NT/N gene in the brain.

AB - In this chapter, we have presented evidence for several potential levels of interaction of NT/N gene products with dopaminergic systems of the brain. We have focused on one manifestation of this interaction related to the effects of antipsychotic drugs on expression of the NT/N gene in two anatomically discrete populations of neurons. It appears that certain antipsychotic drugs can dramatically increase expression of this gene in the dorsolateral striatum by blocking dopamine D2 receptors, perhaps by increasing expression of the gene encoding the transcriptional regulator fos. In addition, a second group of NT cells in the shell region of the nucleus accumbens also respond to these drugs by increasing NT/N gene expression. Several other peptides have been suggested to respond to treatment with antipsychotic drugs. However, there are some important differences with respect to their effects on the NT cells we have studied. The most important of these is the differential responsiveness of the DLSt and nucleus accumbens NT neurons to typical and atypical antipsychotics. We showed that all antipsychotic drugs tested increased NT/N mRNA gene expression in the accumbens, a region thought to be involved in dopaminergic disturbances underlying psychosis. However, only the typical neuroleptics that have a high propensity to induce acute extrapyramidal motor side effects influenced NT/N gene expression in the dorsolateral striatum, a structure importantly involved in regulation of motor functions. We hypothesize, therefore, that NT/N-expressing neuronal systems in the nucleus accumbens may mediate some or all of the antipsychotic effects, whereas those in the dorsolateral striatum may be involved in motor effects of neuroleptic drugs. Thus, examination of the effects of these drugs on these neuronal populations will not only clarify their mechanism of action, but in addition may provide a useful 'screening' assay for new drugs with enhanced antipsychotic activity, but reduced propensity to induce the debilitating extrapyramidal side effects that are a major cause of patient noncompliance. Future studies will focus on the effects of antipsychotic drugs on NT neurons in clinically relevant models of chronic administration, and on the molecular events involved in their effects on expression of the NT/N gene in the brain.

UR - http://www.scopus.com/inward/record.url?scp=0027070809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027070809&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1992.tb27339.x

DO - 10.1111/j.1749-6632.1992.tb27339.x

M3 - Article

C2 - 1361120

AN - SCOPUS:0027070809

VL - 668

SP - 54

EP - 69

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -